4 withdrawn. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Withdrawn 4 |
| Phase 2 | 4 | Withdrawn 4 |
Follow Stomatitis: new trials by email Literature Review of Stomatitis trials Research Report on Stomatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis Clobetasol 0.05% ointment, Placebo - Toxic Epidermal Necrolysis | Phase 1 / Phase 2 | Withdrawn | University of California, Davis | 2016-11-01 | 2019-08-09 | |
| Topical Infliximab in Autoimmune Eyes With Keratoprosthesis topical infliximab - Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (Lyell) Syndrome | Phase 1 / Phase 2 | Withdrawn | James Chodosh, MD, MPH | 2014-11-01 | 2017-04-07 | |
| Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS) Infliximab - Stevens-Johnson Syndrome, Corneal Blindness | Phase 1 / Phase 2 | Withdrawn | Massachusetts Eye and Ear Infirmary | 2010-12-01 | 2015-11-04 | |
| A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy Placebo, palifermin - Head and Neck Cancer | Phase 1 / Phase 2 | Withdrawn | Swedish Orphan Biovitrum | 2007-10-01 | 2009-03-02 |
Stevens-Johnson Syndrome (3) · Head and Neck Neoplasms (1) · Neoplasms (1) · Pemphigoid, Benign Mucous Membrane (1) · Syndrome (1)
Mouth Diseases (4) · Stomatognathic Diseases (4) · Chemically-Induced Disorders (3) · Dermatitis (3) · Drug Eruptions (3) · Drug Hypersensitivity (3) · Drug-Related Side Effects and Adverse Reactions (3) · Erythema (3) · Erythema Multiforme (3) · Hypersensitivity (3) · Hypersensitivity, Delayed (3) · Immune System Diseases (3) · Skin Diseases (3) · Skin Diseases, Vesiculobullous (3) · Skin and Connective Tissue Diseases (3)
Infliximab (2) · Clobetasol (1) · Fibroblast Growth Factor 7 (1) · Ointments (1)
James Chodosh, MD, MPH (1) · Massachusetts Eye and Ear Infirmary (1) · Swedish Orphan Biovitrum (1) · University of California, Davis (1)
United States (3) · Canada (1)
James Chodosh, MD, MPH (2) · Claes H Dohlman, MD, PhD (1) · Emanual Maverakis, MD (1) · Mona Harissi-Dagher, MD (1)